Tectonic Therapeutic | AVRO - Interest Income


Tectonic Therapeutic reported $1.74M in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Alnylam Pharmaceuticals USD 26.63M 2.05M Dec/2025
Celltrion KRW 621.35M 55.31M Dec/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Gilead Sciences USD 95M 7M Dec/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Kangmei Pharma CNY 2.44M 635.78K Mar/2026
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
MacroGenics USD 1.53M 114K Sep/2025
Medical Developments International AUD 174K 31K Dec/2024
Pfizer USD 115M 51M Mar/2026
Pharma Mar EUR 1.63M 3.17M Dec/2025
Qiagen NV USD 20M 4.93M Dec/2025
Sanofi EUR 33M 81M Dec/2025
Sarepta Therapeutics USD 8.74M 359K Dec/2025
Sartorius EUR -31.8M 86.7M Dec/2025
Takeda JPY 87.87B 43.48B Dec/2025
Tilray USD 12.83M 20.19M May/2024
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M Mar/2026